Cargando…

Follicle-Stimulating Hormone Does Not Impact RANKL-Induced Osteoclastogenesis

Postmenopausal osteoporosis has been attributed to decreased estradiol levels. In the hypothalamic-pituitary-gonadal axis, estradiol synthesis is stimulated by follicle-stimulating hormone (FSH). FSH is secreted from the anterior pituitary gland and estradiol feeds back to the hypothalamus and pitui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ziyue, Gambino, Luisina Ongaro, Bernard, Daniel J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089317/ http://dx.doi.org/10.1210/jendso/bvab048.474

Ejemplares similares

OR13-05 Longitudinal Changes In Bone Turnover Following Withdrawal Of RANKL Inhibition
por: Kim, Albert S, et al.
Publicado: (2023)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

SUN-532 Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis
por: Imel, Erik, et al.
Publicado: (2019)

MON-LB72 Multicentric Carpotarsal Osteolysis Syndrome (MCTO) Has a Generalized High Turnover Bone Phenotype, High S RANKL and Responds to Denosumab
por: Regev, Ravit, et al.
Publicado: (2020)

SAT667 Follicle-Stimulating Hormone Does Not Directly Regulate Adipogenesis Via The FSH Receptor In Mice
por: Loka, Mary, et al.
Publicado: (2023)

MON-537 Fusion of Parathyroid Hormone to Growth Hormone Binding Protein Delays Clearance Whilst Retaining Biological Activity
por: Wilkinson, Ian, et al.
Publicado: (2019)

MON-352 When Osteoporosis Does Not Make Sense: Tumor-Induced Osteomalacia
por: Techathaveewat, Pawarid, et al.
Publicado: (2020)

SAT-385 A Normal FGF23 Does Not Preclude Tumor Induced Osteomalacia (TIO)
por: Nandam, Neeharika, et al.
Publicado: (2020)

SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia
por: DeLacey, Sean, et al.
Publicado: (2019)

SUN-499 An Unusual Case of a Misleading Elevated Parathyroid Hormone Level
por: Burks, Margaret, et al.
Publicado: (2019)

RF30 | PSAT135 Rare Case of Hypercalcemia Mediated by an Ectopic Parathyroid Hormone (PTH), and Parathyroid Hormone-Related Peptide (PTHrP) Co-Secretion Secondary to Metastatic Cervical Carcinoma
por: Gaballa, Salem, et al.
Publicado: (2022)

LBODP023 Popular Supplements Containing Plant Extracts With High Biotin Content Can Severely Impact Parathyroid Hormone (PTH) Measurements Leading To A False Suspicion Of Primary Hyperparathyroidism (PHP).
por: Wozniak, Zofia, et al.
Publicado: (2022)

ODP110 Parathyroid Hormone Independent Hypercalcaemia Secondary to Granulomatous Inflammation: Could This Be Melioidosis?
por: Grace, Samuel, et al.
Publicado: (2022)

SAT-387 Testing for Parathyroid Hormone: Performances of a Novel Fully Chemiluminescent Automated Assay
por: Gruson, Damien, et al.
Publicado: (2020)

SAT191 Primary Hyperparathyroidism With Low-Normal Parathyroid Hormone Levels: Phosphorus Can Be The Key
por: He, Diana, et al.
Publicado: (2023)

Methadone Maintenance Treatment, Sex Hormones and Low Bone Density in a Population of Injection Drug Users
por: Wehbeh, Leen, et al.
Publicado: (2021)

RF06 | PSAT152 Associations between Bone Mass, Hormone Levels and Body Composition in Postmenopausal Women
por: Fighera, Tayane, et al.
Publicado: (2022)

MON-536 Improving the Accuracy and Reliability of Parathyroid Hormone Measurements by Establishing a Mass Spectrometric Reference Measurement Procedure
por: Ulmer, Candice, et al.
Publicado: (2019)

SUN-348 Growth Hormone Replacement in Adults During 8 Years Leads to Sustained Increase in Bone Mineral Density
por: Payer, Juraj, et al.
Publicado: (2020)

The Role of Thyroid Hormone 3,3 ‘, 5 - Triiodothyronine (T3) in the Expression of Osteocalcin and Lipocalin 2 (LCN2) in Osteoblasts
por: de Camargo Andrade, Amanda Fantini, et al.
Publicado: (2021)

ODP109 PARATHYROID HORMONE AND 25 OH VITAMINA D IN PREGNANCY: DATA FROM AN ARGENTINEAN COHORT SUPPORTING SUPPLEMENTATION.
por: Torres, Marta Isabel, et al.
Publicado: (2022)

OR30-4 Parathyroid Hormone-related Peptide Antagonist and Inverse Agonist Reduce Breast Cancer Metastasis to Bone and Bone Loss
por: Ponnapakkam, Tulasi, et al.
Publicado: (2019)

SAT255 Dual Cause Of Hypercalcemia: Can Both Multiple Myeloma And Paraneoplastic Parathyroid-related Hormone Production Occur Simultaneously?
por: Shah, Anvay, et al.
Publicado: (2023)

Chronic Stimulation of Arcuate Kiss1 Neurons Decreases Bone Mass in Female Mice
por: Rodriguez, Ruben, et al.
Publicado: (2021)

SUN-534 Effect of Cross-Sex Hormone Therapy on Body Composition, Visceral Adipose Tissue, and Bone Mineral Density in Transgender Men
por: Fighera, Tayane, et al.
Publicado: (2019)

Improving the Accuracy and Reliability of Parathyroid Hormone Levels Through the Mass-Spectrometric Measurement of Full-length PTH and C-Terminal PTH Fragments
por: Ulmer, Candice Z, et al.
Publicado: (2021)

FRI675 Higher FSH Level Is Associated With Increased Risk Of Incident Hip Fracture In Older Adults, Independent Of Sex Hormone Levels
por: Koh, Eileen H, et al.
Publicado: (2023)

SUN-337 Low Dose Ethinyl Estradiol in Women with Cystic Fibrosis Does Not Preserve Bone Mass
por: Wu, Malinda, et al.
Publicado: (2020)

OR29-03 The Effects of Hormone Therapy on Premature Ovarian Failure Following Allogenic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
por: Ha, Jeonghoon, et al.
Publicado: (2020)

MON-LB73 Incidence Rate of Post-Thyroidectomy Immediate Hypocalcemia and Its Relation to Pre-Operative Vitamin D and Parathyroid Hormone Levels
por: Sirajuddin, Khadeeja, et al.
Publicado: (2020)

LBSAT142 Discovery And Characterization Of A Potent And Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist For The Treatment Of Hypercalcemia
por: Rico-Bautista, Elizabeth, et al.
Publicado: (2022)

THU413 Does Continuous Positive Airway Pressure Affect Bone Loss Process In The Population Of Sleep Apnea?
por: Chen, Yi-Ju, et al.
Publicado: (2023)

OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled Trials
por: Wolf, Myles, et al.
Publicado: (2019)

OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study
por: Bilezikian, John, et al.
Publicado: (2019)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension
por: Rubin, Mishaela R, et al.
Publicado: (2021)

MON-373 Low Bone Mineral Density Does Not Equal Osteoporosis: The Finding of XLHR with a Novel Phex Mutation
por: Tran, Kelvin, et al.
Publicado: (2020)

SAT182 Effects Of An Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist In Rodent Models Of Primary Hyperparathyroidism (PHPT)
por: Antwan, Agnes S, et al.
Publicado: (2023)

SAT236 Pharmacokinetics (PK) And Pharmacodynamics (PD) Of The Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered Via An Orally Administered Robotic Pill (RT-102)
por: Horlen, Kyle, et al.
Publicado: (2023)

SAT-514 The Decrease in Serum Parathyroid Hormone on Vitamin D Treatment Is Similar When Comparing Increases in Serum Free or Total 25 Hydroxyvitamin D in White and Black Women
por: Smith, Lynette, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ovjrah2hdguc5v1erdhlj72hm9